-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Fresenius Medical Care, Lowers Price Target to $24

Benzinga·10/12/2026 18:15:04
Listen to the news
Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:FMS) with a Hold and lowers the price target from $25 to $24.